Status:

COMPLETED

ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough

Lead Sponsor:

Kefang Lai

Conditions:

Refractory/Unexplained Chronic Cough

Eligibility:

All Genders

18+ years

Brief Summary

This is a cross-sectional study to investigate ATP level in induced sputum and cough sensitivity to ATP in subjects with refractory/unexplained chronic cough. 60 patients with refractory/unexplained c...

Eligibility Criteria

Inclusion

  • Inclusion criteria for patients:
  • ≥18 years old
  • cough as sole symptom lasting ≥6 months
  • cough visual analogue score ≥30mm
  • diagnosed as RCC/UCC according to guidelines
  • Exclusion criteria for patients:
  • smoking currently or in the past 6 months, or a smoking history of \>20 pack-year
  • a forced expiratory volume in 1 second/forced vital capacity ratio \<70%;
  • use of inhaled/oral corticosteroid, bronchodilators, anti-allergic medicine, antitussive medicine or anti-reflux treatment in the past 1 week;
  • a history of acute respiratory infection in the past 4 weeks;
  • a history of severe disease (cancer, acute coronary syndrome and so on).
  • Healthy control aged ≥18 years old are included. Exclusion criteria are as follow:
  • smoking currently or in the past 6 months, or a smoking history of \>20 pack-year
  • a forced expiratory volume in 1 second/forced vital capacity ratio \<70%
  • a history of acute respiratory infection in the past 4 weeks
  • posstive findings of chest radiography
  • a history of chronic respiratory disease and allergic disease
  • any signs of cough hypersensitivity

Exclusion

    Key Trial Info

    Start Date :

    May 16 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    January 24 2024

    Estimated Enrollment :

    131 Patients enrolled

    Trial Details

    Trial ID

    NCT05265871

    Start Date

    May 16 2022

    End Date

    January 24 2024

    Last Update

    May 11 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China